It is a pharma private limited company based in Baddi, Himachal Pradesh, India, established in 2020.
2020 | Baddi, Himachal Pradesh, India | ActiveSorbax Pharmaceuticals Private Limited, a active private limited company, was established on 15 October 2020 in Baddi, Himachal Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290HP2020PTC008140. Registered under ROC Roc Himachal Pradesh. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 13 professional, Its leadership includes Dheeraj Gangadhara Shetty (Director), Manjeet Kaur (Additional Director), Kota Suresh Prabhu (Director). Past directors included Krishan Chand Raghu. It holds ₹5.05 Cr open charges and ₹4.04 Cr settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Plot No.112-A, Hpsidc Industrial Estate Davni, Teh. Baddi, Distt. Solan, Baddi, Himachal Pradesh, 173205.
U24290HP2020PTC008140
008140
15 October 2020
₹1.00 Cr
₹1.00 Cr
Roc Himachal Pradesh
Unlisted
Active
Explore comprehensive insights into Sorbax Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dheeraj Gangadhara Shetty | Director | 24 Feb 2021 | Current |
| Manjeet Kaur | Additional Director | 26 Apr 2024 | Current |
| Kota Suresh Prabhu | Director | 15 Oct 2020 | Current |
| Lalan Kumar Singh | Director | 15 Oct 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Mar 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sorbax Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11661.87% increase. The company also saw a substantial improvement in profitability, with a 108.11% increase in profit. The company's net worth Soared by an impressive increase of 171.45%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sorbax Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹50,500,000.00
₹40,402,853.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Mar 2023 | Others | ₹5.05 Cr | Open |
| 13 Jul 2021 | Karnataka Bank Ltd. | ₹4.04 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sorbax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sorbax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sorbax Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Manjeet Kaur was appointed as a Additional Director was appointed as a Additional Director on 26 Apr 2024 & has been associated with this company since 1 year 7 months . was documented.
Sorbax Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
A charge registered on 13 Jul 2021 via Charge ID 100467096 with Karnataka Bank Ltd. was fully satisfied on 10 May 2023. was recorded as a recent event.
Sorbax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Himachal Pradesh. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 5.05 Cr with Charge ID 100734512 was registered on 27 Mar 2023. was completed.
Progress on A charge with Karnataka Bank Ltd. amounted to Rs. 4.04 Cr with Charge ID 100467096 was registered on 13 Jul 2021. was documented.
The CIN of Sorbax Pharmaceuticals Private Limited is U24290HP2020PTC008140.
Sorbax Pharmaceuticals Private Limited is headquartered at Plot No.112-A, Hpsidc Industrial Estate Davni, Teh. Baddi, Distt. Solan, Baddi, Himachal Pradesh, 173205.
Sorbax Pharmaceuticals Private Limited was incorporated on 15 October 2020.
The current directors of Sorbax Pharmaceuticals Private Limited are
The primary industry of Sorbax Pharmaceuticals Private Limited is Manufacturing.
Sorbax Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sorbax Pharmaceuticals Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Sorbax Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX